memo - Magazine of European Medical Oncology 4/2021

01.12.2021 | ASCO 2021 | editorial

Best of ASCO 2021

Ewald Wöll

01.12.2021 | editorial

Practical issues in hematology

Klaus Geissler

01.12.2021 | editorial

Rare lung cancers—2021 update on challenges, advances, and opportunities

Andreas Pircher

Open Access 26.10.2021 | ASCO 2021 | short review

ASCO 2021—an update on metastastic colorectal cancer

Lukas Weiss

PDF-Version jetzt herunterladen Zum Volltext

Open Access 11.10.2021 | ASCO 2021 | short review

ASCO 2021: Highlights in central nervous system tumors

Maximilian J. Mair, Anna S. Berghoff

PDF-Version jetzt herunterladen Zum Volltext

Open Access 04.10.2021 | ASCO 2021 | short review

Best of ASCO 2021: new data from triple-negative breast cancer

Christian Singer

PDF-Version jetzt herunterladen Zum Volltext

Open Access 27.10.2021 | ASCO 2021 | short review

ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma

Thorsten Fuereder

PDF-Version jetzt herunterladen Zum Volltext

25.10.2021 | ASCO 2021 | short review

Best of ASCO 2021—bladder cancer

Karl Mayrhofer, Dora Niedersüß-Beke

Open Access 08.10.2021 | ASCO 2021 | short review

ASCO 2021–Gastroesophageal tumor highlights

Aysegül Ilhan-Mutlu

PDF-Version jetzt herunterladen Zum Volltext

21.10.2021 | ASCO 2021 | short review

Ovarian cancer—ASCO annual meeting update 2021

Johannes Schöche, Kathrin Strasser-Weippl

Open Access 18.10.2021 | ASCO 2021 | review

ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer

Gudrun Absenger, Andreas Pircher

PDF-Version jetzt herunterladen Zum Volltext

18.10.2021 | review

Practical considerations for the management of immune thrombocytopenic purpura

Michael Fillitz, Barbara Dixer, Felix Keil

12.10.2021 | short review

Pancytopenia—a diagnostic challenge?

Klaus Geissler

29.10.2021 | short review

Laboratory thrombophilia screening: essentials for hematologists

Paul A. Kyrle

18.06.2021 | original report

Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL)

Rasha I. Ibrahim, Haydi S. Mohamed, Mary G. Nagib, Hebatullah M. Fares, Alia M. Saeed

20.08.2021 | comment

The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours

Wolfgang Jungraithmayr

Open Access 17.08.2021 | short review

Unresectable pleural mesothelioma—hope or still an unmet medical need?

Gudrun Absenger, Angelika Terbuch

PDF-Version jetzt herunterladen Zum Volltext

Open Access 21.05.2021 | short review

Neuroendocrine neoplasms of the lung: a pathology update

Jasna Metovic, Marco Barella, Giuseppe Pelosi

PDF-Version jetzt herunterladen Zum Volltext

06.07.2021 | case report

Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib

A case report

Louisa Hempel, Jakob Molnar, Andreas Gaumann, Sebastian Robert, Josef Scheiber, Axel Kleespies, Kristina Riedmann, Susanne Schreiber, Beate Gandorfer, Armin Piehler, Dirk Hempel

Open Access 20.08.2021 | case report

Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report

Laurenz Nagl, Andreas Seeber, Gerlig Widmann, Katja Schmitz, Herbert Maier, Georg Pall, Dominik Wolf, Andreas Pircher

PDF-Version jetzt herunterladen Zum Volltext

Open Access 08.11.2021 | short review

The value of immunotherapy in pediatric leukemia and lymphoma

Elisabeth Salzer, Andishe Attarbaschi

PDF-Version jetzt herunterladen Zum Volltext

20.09.2021 | case report

Ponatinib and palbociclib combination in TKI-resistant CML—A case report

Johannes B. Jaeger, Thomas Jaeger, Sandra Preuner, Petra Pusic, Isabella Sponseiler, Thomas Lion, Thomas Winder, Bernd Lorenz Hartmann

04.10.2021 | review

Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma?

A chronological narrative literature review

Wael Khair

Springer Medizin Österreich

memo - Magazine of European Medical Oncology

Ausgabe 4/2021

Inhaltsverzeichnis (23 Artikel)

Best of ASCO 2021

Practical issues in hematology

Rare lung cancers—2021 update on challenges, advances, and opportunities

ASCO 2021—an update on metastastic colorectal cancer

ASCO 2021: Highlights in central nervous system tumors

Best of ASCO 2021: new data from triple-negative breast cancer

ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma

Best of ASCO 2021—bladder cancer

ASCO 2021–Gastroesophageal tumor highlights

Ovarian cancer—ASCO annual meeting update 2021

ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer

Practical considerations for the management of immune thrombocytopenic purpura

Pancytopenia—a diagnostic challenge?

Laboratory thrombophilia screening: essentials for hematologists

Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL)

The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours

Unresectable pleural mesothelioma—hope or still an unmet medical need?

Neuroendocrine neoplasms of the lung: a pathology update

Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib

Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report

The value of immunotherapy in pediatric leukemia and lymphoma

Ponatinib and palbociclib combination in TKI-resistant CML—A case report

Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma?

Aktuelle Ausgaben

Sonderheft 10/2022

Ausgabe 4/2022

Sonderheft 9/2022

Sonderheft 8/2022

Sonderheft 6/2022

Sonderheft 7/2022

Ausgabe 3/2022

Sonderheft 5/2022

Sonderheft 4/2022

Ausgabe 2/2022